Nuclear receptors in renal disease
- 31 August 2011
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1812 (8), 1061-1067
- https://doi.org/10.1016/j.bbadis.2011.04.003
Abstract
No abstract availableKeywords
Funding Information
- NIH (U01 DK076134 and R01 AG026529)
- VA Merit Review
This publication has 120 references indexed in Scilit:
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialThe Lancet, 2010
- Plasma membrane estrogen receptorsTrends in Endocrinology & Metabolism, 2009
- Transgenic expression of proximal tubule peroxisome proliferator–activated receptor-α in mice confers protection during acute kidney injuryKidney International, 2009
- Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized TrialAmerican Journal of Kidney Diseases, 2009
- Estrogens and the diabetic kidneyGender Medicine, 2008
- Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increaseProceedings of the National Academy of Sciences of the United States of America, 2008
- Oral Calcitriol for the Treatment of Persistent Proteinuria in Immunoglobulin A Nephropathy: An Uncontrolled TrialAmerican Journal of Kidney Diseases, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Regulation of Transforming Growth Factor β in Diabetic Nephropathy: Implications for TreatmentSeminars in Nephrology, 2007
- Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosisThe Journal of Steroid Biochemistry and Molecular Biology, 2007